Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

ECBF Leads €17m Series A Round of RED Horticulture (2023-11-21)
> ECBF expands its agricultural technology portfolio with an investment in company RED Horticulture > LED photobiological lighting solutions powered by RED's proprietary AI platform reduce energy consumption of greenhouses by up to 60 percent and increase crop q...
Recipharm: Marc Funk Moves to BoD; Greg Behar New CEO (2023-11-21)
Recipharm, a leading, global player in the pharmaceutical CDMO industry, announces today the appointment of Greg Behar as Chief Executive Officer. Marc Funk, who successfully led Recipharm into its next phase of growth, will join the Board of Directors, where he wi...
NMD Pharma Raises €75m Series B Led by Jeito Capital (2023-11-15)
> Proceeds will be used to complete three Phase 2 clinical studies of first-in-class ClC-1 molecule inhibitor NMD670 in myasthenia gravis, spinal muscular atrophy and Charcot-Marie-Tooth disease > In addition, NMD Pharma will continue to mature and expand its p...
T-Therapeutics Raises £48m Series A Round (2023-11-15)
> Fundraise led by Sofinnova Partners, F-Prime Capital, Digitalis Ventures and Cambridge Innovation Capital with participation from Sanofi Ventures and the University of Cambridge Venture Fund > Unique transgenic mouse platform harnesses natural power of T cells...
Nouscom Raises €67.5m in Oversubscribed Series C Round (2023-11-14)
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key clinical proof of concept endpoints Nouscom, a clinical stage ...
Valneva: FDA Approves World’s First Chikungunya Vaccine (2023-11-10)
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has approved IXCHIQ®, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease caused by chik...
Valneva to Present at Jefferies London Healthcare Conference (2023-11-07)
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at the Jefferies London Healthcare Conference, to take place Novembe...
Inari Medical to Acquire LimFlow for up to $451m (2023-11-01)
LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has entered into a definitive agreement to be acquired...
MeiraGTx Announces $30m Strategic Investment from Sanofi (2023-10-30)
> Sanofi to purchase $30 million of ordinary shares of the Company at a price of $7.50 per share > Sanofi to receive a right of first negotiation (ROFN) for the use of MeiraGTx’s Riboswitch gene regulation technology for certain Immunology and Inflammation (I&I)...
Abivax Closes €223.3m Global Offering & US IPO at Nasdaq (2023-10-24)
Abivax SA (Euronext Paris:FR0012333284 - ABVX) (" Abivax " or the " Company "), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic ...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture Twist Bioscience Biopharma Solutions Our Gold Standard 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)